Showing results (411-420 of 454) with videos related to
Sort By:
Pageof 46
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trialsEric Lawitz, Maria Buti, John M Vierling, et al.Hepatology (Baltimore, Md.)|February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registryCarlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.Revista Espanola De Enfermedades Digestivas|December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liverJoaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.Journal of Virology|April 20, 2018
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T CellsHadi Karimzadeh, Muthamia M Kiraithe, Anna D Kosinska, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver DiseaseZobair M Younossi, Janus P Ong, Hirokazu Takahashi, et al.Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.Gut|June 4, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transitionRui Huang, Huy N Trinh, Satoshi Yasuda, et al.Pageof 46